ICU Medical Inc (ICUI)
Official siteHEALTHCARE • MEDICAL INSTRUMENTS & SUPPLIES • NASDAQ
Market Cap: $4.48B
Last updated: Nov 17, 2026 at 11:06 AM ET
ICU Medical Inc (ICUI) Stock Forecast
Analysts expect ICU Medical (ICUI) to earn $8.93 per share in the fiscal year ending Dec 31, 2026, on revenue of $2.19B. Of 8 analysts, 7 rate the stock Buy or Strong Buy, 1 Hold and 0 Sell or Strong Sell, for a consensus of Buy. For the fiscal year ending Dec 31, 2027, the EPS consensus is $9.68.
Analyst Ratings
Scoring Strong Buy as 1 and Strong Sell as 5, the 8 ratings average 1.75, inside the Buy band from 1.5 up to 2.5. Buy and Strong Buy make up 88% of the ratings.
| Rating | Analysts | Share |
|---|---|---|
| Strong Buy | 3 | 37.5% |
| Buy | 4 | 50.0% |
| Hold | 1 | 12.5% |
| Sell | 0 | 0.0% |
| Strong Sell | 0 | 0.0% |
- Consensus
- Buy
- Total analysts
- 8
Price Target
Analyst price targets are part of paid GNG plans. See plans
Annual Estimates
From the first fiscal year below to the second, the EPS consensus rises 8.4% and revenue estimates rise 4.6%.
- Fiscal year ending Dec 31, 2026
- $8.93
- EPS consensus, revenue $2.19B
- Fiscal year ending Dec 31, 2027
- $9.68
- EPS consensus, revenue $2.29B
- Next report
- Feb 17, 2027
- Estimated
EPS range
Revenue range
| Fiscal year ending | EPS consensus | EPS range | EPS analysts | Revenue consensus | Revenue range | Rev. analysts |
|---|---|---|---|---|---|---|
| Dec 31, 2026 | $8.93 | $8.88 to $9.00 | 8 | $2.19B | $2.18B to $2.21B | 8 |
| Dec 31, 2027 | $9.68 | $9.35 to $10.00 | 8 | $2.29B | $2.26B to $2.33B | 8 |
Quarterly Estimates
The EPS consensus falls from $2.21 for the quarter ending Dec 31, 2026 to $2.14 for the quarter ending Mar 31, 2027.
EPS range
Revenue range
| Quarter ending | EPS consensus | EPS range | EPS analysts | Revenue consensus | Revenue range | Rev. analysts |
|---|---|---|---|---|---|---|
| Dec 31, 2026 | $2.21 | $2.08 to $2.38 | 9 | $570.49M | $543.70M to $594.93M | 9 |
| Mar 31, 2027 | $2.14 | $2.10 to $2.16 | 4 | $545.50M | $543.30M to $548.40M | 3 |
Estimate Revisions
Across the 2 periods below, the last 30 days brought 11 upward and 1 downward EPS revisions. Raises outnumber cuts in every period.
| Period | Up 30 days | Down 30 days |
|---|---|---|
| Fiscal year ending Dec 31, 2027 | 7 | 1 |
| Quarter ending Mar 31, 2027 | 4 | 0 |
EPS Trend
Over the last 90 days, the EPS consensus for the fiscal year ending Dec 31, 2026 has risen 2.1% from $8.75.
| Period | Now | 7 days ago | 30 days ago | 60 days ago | 90 days ago | Change |
|---|---|---|---|---|---|---|
| Fiscal year ending Dec 31, 2026 | $8.93 | $8.75 | $8.75 | $8.75 | $8.75 | +2.1% |
| Fiscal year ending Dec 31, 2027 | $9.68 | $9.65 | $9.65 | $9.65 | $9.65 | +0.3% |
| Quarter ending Mar 31, 2027 | $2.14 | $2.15 | $2.15 | $2.15 | $2.15 | -0.6% |
Frequently Asked Questions About ICUI
What is the ICUI stock forecast?
Consensus analyst estimates put ICU Medical's EPS at $8.93 for the fiscal year ending Dec 31, 2026, on revenue of $2.19B. The consensus rating from 8 analysts is Buy.
How do analysts rate ICUI stock?
Of 8 analysts covering ICU Medical, 3 rate it Strong Buy, 4 Buy, 1 Hold, 0 Sell and 0 Strong Sell, for a consensus of Buy.
What EPS do analysts expect from ICUI next year?
For the fiscal year ending Dec 31, 2026, the consensus EPS estimate is $8.93, with estimates from $8.88 to $9.00 from 8 analysts. For the fiscal year ending Dec 31, 2027, the consensus EPS estimate is $9.68, with estimates from $9.35 to $10.00 from 8 analysts.
What revenue do analysts expect from ICU Medical next year?
For the fiscal year ending Dec 31, 2026, the consensus revenue estimate is $2.19B, with estimates from $2.18B to $2.21B. For the fiscal year ending Dec 31, 2027, the consensus revenue estimate is $2.29B, with estimates from $2.26B to $2.33B.
How many analysts cover ICUI?
8 analysts rate ICU Medical stock, and 8 analysts estimate its EPS for the fiscal year ending Dec 31, 2026.
ICUI pages: Overview, Earnings, Forecast, Financials, Valuation, Competitors, Government Contracts